Glaukos Corp Dividends
| GKOS Stock | USD 121.00 14.36 13.47% |
Dividends Paid is likely to drop to about 7.1 M in 2026. Dividend Paid And Capex Coverage Ratio is likely to drop to -9.2 in 2026. Glaukos Corp's past performance could be the main factor of why investors trade Glaukos Corp stock today. Investors should clearly understand every aspect of the Glaukos Corp dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Glaukos Corp's dividend schedule and payout information. Glaukos Corp dividends can also provide a clue to the current valuation of Glaukos Corp.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 7.4 M | 7.1 M | |
| Dividend Paid And Capex Coverage Ratio | (8.76) | (9.20) |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Glaukos Corp must own a stock before its ex-dividend date to receive its next dividend.
Glaukos Corp Dividends Paid Over Time
Today, most investors in Glaukos Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Glaukos Corp's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Glaukos Corp dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Is there potential for Health Care Equipment & Supplies market expansion? Will Glaukos introduce new products? Factors like these will boost the valuation of Glaukos Corp. Market participants price Glaukos higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Glaukos Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 18.963 | Earnings Share (1.54) | Revenue Per Share | Quarterly Revenue Growth 0.381 | Return On Assets |
Investors evaluate Glaukos Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Glaukos Corp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Glaukos Corp's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Glaukos Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Glaukos Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Glaukos Corp's market price signifies the transaction level at which participants voluntarily complete trades.